{"product_id":"mgh-psychopharmacology-neurotherapeutics-ca-0443119724","title":"Massachusetts General Hospital Psychopharmacology and Neurotherapeutics","description":"\u003ch2\u003eAbout the Editors\u003c\/h2\u003e\u003cp\u003eTheodore A. Stern, MD, Joan A. Camprodon, MD, MPH, PhD, Maurizio Fava, MD, and their colleagues are internationally recognized authorities in psychopharmacology and neurotherapeutics. All are faculty at Harvard Medical School and practising clinicians at Massachusetts General Hospital, where they lead clinical and research programmes shaping the future of psychiatric treatment. Their collective expertise spans mood disorders, psychotic disorders, neuropsychiatry, and interventional psychiatry.\u003c\/p\u003e\u003ch2\u003eWho Should Buy This Book?\u003c\/h2\u003e\u003cp\u003eThis book is intended for:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003ePsychiatry residents and fellows seeking a thorough foundation in psychopharmacology and neurotherapeutics.\u003c\/li\u003e\n\u003cli\u003ePractising psychiatrists and psychiatric nurse practitioners wanting to update their knowledge and incorporate neurotherapeutic options.\u003c\/li\u003e\n\u003cli\u003ePrimary care physicians and internists who manage psychiatric conditions and need a reliable reference.\u003c\/li\u003e\n\u003cli\u003eResearchers and academics interested in the current state of clinical psychopharmacology and neuromodulation.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eOverview\u003c\/h2\u003e\u003cp\u003eMassachusetts General Hospital Psychopharmacology and Neurotherapeutics is a comprehensive clinical reference designed for psychiatrists, residents, and other mental health professionals. Edited by leading experts from one of the world's top academic medical centres, this book distills cutting-edge research and clinical wisdom into practical guidance for treating psychiatric disorders. The text bridges traditional psychopharmacology with emerging neurotherapeutic interventions, offering an evidence-based framework for personalized patient care.\u003c\/p\u003e\u003ch2\u003eKey Features\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive coverage\u003c\/strong\u003e of psychiatric medications, from antidepressants and antipsychotics to mood stabilizers and anxiolytics, including mechanisms of action, dosing, side effects, and drug interactions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeurotherapeutics integration\u003c\/strong\u003e explores neuromodulation techniques such as transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), and deep brain stimulation (DBS) as well as emerging approaches like ketamine and psychedelic-assisted therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpert authorship\u003c\/strong\u003e by board-certified clinicians and researchers at Massachusetts General Hospital, ensuring credibility and practical relevance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical algorithms\u003c\/strong\u003e and treatment decision trees to guide pharmacologic and neurotherapeutic selection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEvidence-based recommendations\u003c\/strong\u003e grounded in the latest literature, including meta-analyses and randomized controlled trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpecial populations coverage\u003c\/strong\u003e including children, adolescents, pregnant and breastfeeding women, older adults, and patients with comorbid medical conditions.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eHow This Book Stands Out\u003c\/h2\u003e\u003cp\u003eUnlike many psychopharmacology texts, this volume gives equal weight to neurotherapeutic interventions, reflecting the growing role of device-based and procedural treatments in psychiatry. The MGH brand itself signifies rigorous, evidence-based practice, and the editors have curated contributions from dozens of specialists to ensure depth without sacrificing readability. The book's structure facilitates both quick clinical reference and deep study, with consistent chapter formats that cover pathophysiology, pharmacology, therapeutic protocols, and monitoring. This makes it a valuable tool for board preparation as well as daily practice.\u003c\/p\u003e\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\u003ch3\u003eIs this book suitable for board preparation?\u003c\/h3\u003e\u003cp\u003eYes, the comprehensive coverage of medications, neurotherapeutics, and clinical decision-making aligns with the core content of board examinations in psychiatry. The evidence-based summaries and algorithms are particularly helpful for exam review.\u003c\/p\u003e\u003ch3\u003eDoes the book cover the DSM-5?\u003c\/h3\u003e\u003cp\u003eWhile the primary focus is on pharmacotherapy and neurotherapeutics, the book integrates diagnostic considerations from DSM-5, including specifiers and comorbid conditions, to contextualize treatment choices.\u003c\/p\u003e\u003ch3\u003eIs digital access included?\u003c\/h3\u003e\u003cp\u003eAccess options vary by retailer and format. Many editions offer companion eBook access; please check the product details for your purchase.\u003c\/p\u003e\u003cp\u003e\u003cem\u003eThis book is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.\u003c\/em\u003e\u003c\/p\u003e","brand":"Massachusetts General Hospital","offers":[{"title":"Default Title","offer_id":48331382915310,"sku":null,"price":145.51,"currency_code":"CAD","in_stock":true}],"url":"https:\/\/vitamin4ca.com\/products\/mgh-psychopharmacology-neurotherapeutics-ca-0443119724","provider":"vitamin4ca","version":"1.0","type":"link"}